Search Results - "Feldman, Steven. R"

Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012 by Rogers, Howard W, Weinstock, Martin A, Feldman, Steven R, Coldiron, Brett M

“…Understanding skin cancer incidence is critical for planning prevention and treatment strategies and allocating medical resources. However, owing to lack of…”
Get more information

The Cytokine Mediated Molecular Pathophysiology of Psoriasis and Its Clinical Implications by Singh, Rohan, Koppu, Sindhuja, Perche, Patrick O, Feldman, Steven R

“…Psoriasis is the result of uncontrolled keratinocyte proliferation, and its pathogenesis involves the dysregulation of the immune system. The interplay among…”
Get full text

Interleukin-17 inhibition: role in psoriasis and inflammatory bowel disease by Hohenberger, Megan, Cardwell, Leah A., Oussedik, Elias, Feldman, Steven R.

“…Introduction: Interleukin 17 (IL-17) antagonism provides a highly effective approach for treating psoriasis. Exacerbations of inflammatory bowel disease have…”
Get full text

An assessment of the use of antihistamines in the management of atopic dermatitis by He, Alice, Feldman, Steven R., Fleischer, Alan B.

“…Antihistamines are often used to treat pruritus associated with atopic dermatitis (AD) despite lack of evidence for their efficacy. The American Academy of…”
Get full text

Major Comorbidities of Atopic Dermatitis: Beyond Allergic Disorders by Paller, Amy, Jaworski, Jennifer C., Simpson, Eric L., Boguniewicz, Mark, Russell, John J., Block, Julie K., Tofte, Susan, Dunn, Jeffrey D., Feldman, Steven R., Clark, Adele R., Schwartz, Gene, Eichenfield, Lawrence F.

“…The consequences of atopic dermatitis reach beyond the skin and past childhood. Patients with atopic dermatitis are at risk of developing allergic…”
Get full text

The psychological impact of rosacea and the influence of current management options by Moustafa, Farah, BS, Lewallen, Robin S., MD, Feldman, Steven R., MD, PhD

“…Background Rosacea is a common problem that is underdiagnosed; if left untreated can result in physical disfigurement and emotional distress. Objective We…”
Get full text

Real-world burden of comorbidities in US patients with psoriasis by Shah, Kamal, MD, Mellars, Lillian, MS, Changolkar, Arun, PhD, Feldman, Steven R., MD, PhD

“…Background Understanding background comorbidity rates in psoriasis can provide perspective for adverse events associated with new therapies. Objective We…”
Get full text

Relative efficacy of systemic treatments for atopic dermatitis by Seger, Edward W., Wechter, Todd, Strowd, Lindsay, Feldman, Steven R.

“…Systemic medications are often required for severe atopic dermatitis (AD) refractory to topical therapies. Biologic medications are a recent advancement in the…”
Get full text

Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study by Papp, Kim A., MD, PhD, Krueger, James G., MD, PhD, Feldman, Steven R., MD, PhD, Langley, Richard G., MD, Thaci, Diamant, MD, Torii, Hideshi, MD, PhD, Tyring, Stephen, MD, PhD, Wolk, Robert, MD, PhD, DSc, Gardner, Annie, MS, Mebus, Charles, PhD, Tan, Huaming, PhD, Luo, Yingchun, PhD, Gupta, Pankaj, PhD, Mallbris, Lotus, MD, PhD, Tatulych, Svitlana, MD

“…Background Tofacitinib is an oral Janus kinase inhibitor being investigated for psoriasis. Objectives We sought to report longer-term tofacitinib efficacy and…”
Get full text

Real-world outcomes following switching from anti-TNF reference products to biosimilars for the treatment of psoriasis by Ruda, Rachel C., Kelly, Katherine A., Feldman, Steven R.

“…Tumor necrosis factor (TNF) inhibitors improved clinical outcomes for patients with psoriasis but are limited by their high cost. There are several biosimilar…”
Get full text

Drug tolerability versus drug safety by Prajapati, Stuti, Tao, Rachel, Feldman, Steven R.

Get full text

The Genetic Susceptibility to Psoriasis and the Relationship of Linked Genes to Our Treatment Options by Patel, Heli A, Revankar, Rishab R, Pedroza, Sofia T, Graham, Shaveonte, Feldman, Steven R

“…Understanding the factors creating genetic susceptibility in psoriasis may provide a basis for improving targeted treatment strategies. In this review, we…”
Get full text

Utilizing artificial intelligence technology with emotional intelligence in clinical office visits by Yi, Robin C, Gantz, Hannah Y, Feldman, Steven R

Get full text

Economic burden of comorbidities in psoriasis patients in the United States: results from a retrospective U.S. database by Feldman, Steven R, Tian, Haijun, Gilloteau, Isabelle, Mollon, Patrick, Shu, Meng

“…Psoriasis is a multifactorial, inflammatory, skin disease associated with various comorbidities. The cost of those comorbidities is not well characterized. The…”
Get full text

Mechanisms of microbial pathogenesis and the role of the skin microbiome in psoriasis: A review by Lewis, Daniel J., MD, Chan, Warren H., MS, Hinojosa, Tiffany, MD, Hsu, Sylvia, MD, Feldman, Steven R., MD, PhD

“…AbstractThe pathogenesis of psoriasis may involve a breakdown of immune tolerance to cutaneous microorganisms. Psoriasis is associated with a higher incidence…”
Get full text

A review of phototherapy protocols for psoriasis treatment by Lapolla, Whitney, MD, Yentzer, Brad A., MD, Bagel, Jerry, MD, Halvorson, Christian R., BA, Feldman, Steven R., MD, PhD

“…Phototherapy is a mainstay in the treatment of psoriasis and is available as psoralen plus UVA (PUVA), broadband UVB (BB-UVB), and narrowband UVB (NB-UVB)…”
Get full text

Evaluating adverse events in databases by Lovell, Katie, Feldman, Steven R

“…Abbreviations IL-23 interleukin-23 In this issue, Calapai et al. reported a potential association between oncologic adverse reactions and interleukin-23…”
Get full text

Patient-reported outcomes are important elements of psoriasis treatment decision making: A discrete choice experiment survey of dermatologists in the United States by Feldman, Steven R., Regnier, Stephane A., Chirilov, Alexandra, Hey, Felix, Gilloteau, Isabelle, Cella, David

“…Psoriasis Area and Severity Index (PASI) response rates have been the benchmark for evaluating treatment efficacy in trials involving moderate-to-severe…”
Get full text

Skin Disease in Children: Effects on Quality of Life, Stigmatization, Bullying, and Suicide Risk in Pediatric Acne, Atopic Dermatitis, and Psoriasis Patients by Kelly, Katherine A., Balogh, Esther A., Kaplan, Sebastian G., Feldman, Steven R.

“…Acne, atopic dermatitis (AD), and psoriasis are all chronic dermatologic conditions that greatly impact the lives of pediatric patients and their caregivers…”
Get full text

Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA by Fitzgerald, Timothy, Zhdanava, Maryia, Pilon, Dominic, Shah, Aditi, Hilts, Annalise, Lefebvre, Patrick, Feldman, Steven R.

“…Background Biologics have revolutionized the management of psoriasis, but response to treatment varies. Loss of treatment efficacy may occur over time,…”
Get full text